Cargando…
MgrB Inactivation Confers Trimethoprim Resistance in Escherichia coli
After several decades of use, trimethoprim (TMP) remains one of the key access antimicrobial drugs listed by the World Health Organization. To circumvent the problem of trimethoprim resistance worldwide, a better understanding of drug-resistance mechanisms is required. In this study, we screened the...
Autores principales: | Shi, Hongmei, Li, Ting, Xu, Jintian, Yu, Jifang, Yang, Shanshan, Zhang, Xian-En, Tao, Shengce, Gu, Jing, Deng, Jiao-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355897/ https://www.ncbi.nlm.nih.gov/pubmed/34394028 http://dx.doi.org/10.3389/fmicb.2021.682205 |
Ejemplares similares
-
MgrB Mutations and Altered Cell Permeability in Colistin Resistance in Klebsiella pneumoniae
por: Yap, Polly Soo-Xi, et al.
Publicado: (2022) -
MgrB Alterations Mediate Colistin Resistance in Klebsiella pneumoniae Isolates from Iran
por: Haeili, Mehri, et al.
Publicado: (2017) -
Absence of mgrB Alleviates Negative Growth Effects of Colistin Resistance in Enterobacter cloacae
por: Wozniak, Jessie E., et al.
Publicado: (2020) -
MgrB-Dependent Colistin Resistance in Klebsiella pneumoniae Is Associated with an Increase in Host-to-Host Transmission
por: Bray, Andrew S., et al.
Publicado: (2022) -
Characterization of Amino Acid Substitution W20S in MgrB Involved in Polymyxin Resistance in Klebsiella pneumoniae
por: Roch, Mélanie, et al.
Publicado: (2022)